Rxcurve
Medicare Part B payment limits Effective October 1 – December 31, 2026 Posted by CMS September 17, 2026
HCPCS Q5114 · per 10 MG

Inj ogivri 10 mg

Products billed under this code include Ogivri.

Payment limit per 10 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under Q5114

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Ogivri Viatris - Greenstone LLC 67457-0847-44 42 $1,239.294
Ogivri Viatris - Greenstone LLC 67457-0991-15 15 $442.605
Ogivri Biocon Biologics Inc 83257-0001-11 15 $442.605
Ogivri Biocon Biologics Inc 83257-0004-12 42 $1,239.294

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $29.507 −$2.438 10 MG Inj ogivri 10 mg v1, posted September 17, 2026
3Q26 $31.945 −$3.838 10 MG Inj ogivri 10 mg v1, posted September 15, 2026
2Q26 $35.783 −$1.926 10 MG Inj ogivri 10 mg v1, posted September 15, 2026
1Q26 $37.709 −$2.585 10 MG Inj ogivri 10 mg v1, posted September 15, 2026
4Q25 $40.294 −$4.296 10 MG Inj ogivri 10 mg v1, posted September 8, 2026
3Q25 $44.59 −$2.226 10 MG Inj ogivri 10 mg v1, posted March 10, 2026
2Q25 $46.816 −$5.024 10 MG Inj ogivri 10 mg v1, posted March 10, 2026
1Q25 $51.84 −$2.318 10 MG Inj ogivri 10 mg v1, posted December 19, 2025
4Q24 $54.158 −$1.626 10 MG Inj ogivri 10 mg v1, posted June 11, 2025
3Q24 $55.784 −$6.834 10 MG Inj ogivri 10 mg v1, posted June 11, 2025
2Q24 $62.618 +$18.19 10 MG Inj ogivri 10 mg v1, posted March 11, 2025
1Q24 $44.428 +$4.388 10 MG Inj ogivri 10 mg v1, posted December 19, 2024
4Q23 $40.04 −$0.365 10 MG Inj ogivri 10 mg v1, posted October 10, 2024
3Q23 $40.405 −$6.727 10 MG Inj ogivri 10 mg v1, posted June 5, 2024
2Q23 $47.132 +$4.535 10 MG Inj ogivri 10 mg v1, posted February 23, 2024
1Q23 $42.597 −$2.721 10 MG Inj ogivri 10 mg v1, posted December 6, 2023
4Q22 $45.318 −$2.568 10 MG Inj ogivri 10 mg v1, posted June 22, 2023
3Q22 $47.886 −$2.225 10 MG Inj ogivri 10 mg v1, posted June 9, 2023
2Q22 $50.111 −$5.604 10 MG Inj ogivri 10 mg v1, posted December 14, 2022
1Q22 $55.715 −$4.191 10 MG Inj ogivri 10 mg v1, posted June 8, 2022
4Q21 $59.906 −$3.494 10 MG Inj ogivri 10 mg v1, posted June 2, 2022
3Q21 $63.40 +$2.745 10 MG Inj ogivri 10 mg v1, posted June 2, 2022
2Q21 $60.655 −$12.554 10 MG Inj ogivri 10 mg v1, posted March 1, 2022
1Q21 $73.209 – 10 MG Inj ogivri 10 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files